<p>Panel A and panel C show the time course uptake of RES and PD at the concentration of 15 µmol/L, Panel B and panel D show concentration-dependent uptake of RES and PD in 30 min.</p
Background: The clinic therapeutic effect of resveratrol is limited due to its low oral bioavailabil...
<p>Cells were pre-incubated with 25 µM Resv or 500 µM 5-ASA or both (25 µM Resv plus 500 µM 5-ASA) a...
<p>The initial concentration of resveratrol or FUDR in the medium was 100 µM or 50 µM (0 hr). The me...
<p>Panel A and panel F-negative control; Panel B and panel G-incubating with resveratrol for 5 min; ...
<p>Cultures of MDA-MB-231 cells were treated with varying concentrations of resveratrol and piceid f...
<p>Resveratrol (25 and 100 µM) was added to HaCaT cells for 2 hours (panel A) or 24 hours (panel B) ...
<p>Doses are resveratrol equivalents and data are mean ± SD. Symbols:MeO-PEG-RSV ether 2 kDa, 2 mg/k...
<p>(A) The dose-dependent activation of PPARα by resveratrol, T4HS and 4-PAP in BAECs transiently tr...
BACKGROUND: The clinic therapeutic effect of resveratrol is limited due to its low oral bioavailabil...
Epidemiological and preclinical studies suggest that dietary-derived cancer chemopreventive agents m...
<p>Untreated early passage cells (0D-PT), untreated late passage cells (30D-CM) and cells pretreated...
<p>The effect of resveratrol (res) and IRA 5 on the cell cycle distribution of different cell lines....
<p>The levels of ROS were estimated indirectly by measuring the fluorescence emitted by dichlorofluo...
<p>FRTL-5 cells were grown in 12-well plates to 60% confluency in 6H5% medium, and then shifted to 5...
<p>Cell viability of A) primary human hepatocytes (n = 2), HepG2 and Hep3B cells (n = 3) after stimu...
Background: The clinic therapeutic effect of resveratrol is limited due to its low oral bioavailabil...
<p>Cells were pre-incubated with 25 µM Resv or 500 µM 5-ASA or both (25 µM Resv plus 500 µM 5-ASA) a...
<p>The initial concentration of resveratrol or FUDR in the medium was 100 µM or 50 µM (0 hr). The me...
<p>Panel A and panel F-negative control; Panel B and panel G-incubating with resveratrol for 5 min; ...
<p>Cultures of MDA-MB-231 cells were treated with varying concentrations of resveratrol and piceid f...
<p>Resveratrol (25 and 100 µM) was added to HaCaT cells for 2 hours (panel A) or 24 hours (panel B) ...
<p>Doses are resveratrol equivalents and data are mean ± SD. Symbols:MeO-PEG-RSV ether 2 kDa, 2 mg/k...
<p>(A) The dose-dependent activation of PPARα by resveratrol, T4HS and 4-PAP in BAECs transiently tr...
BACKGROUND: The clinic therapeutic effect of resveratrol is limited due to its low oral bioavailabil...
Epidemiological and preclinical studies suggest that dietary-derived cancer chemopreventive agents m...
<p>Untreated early passage cells (0D-PT), untreated late passage cells (30D-CM) and cells pretreated...
<p>The effect of resveratrol (res) and IRA 5 on the cell cycle distribution of different cell lines....
<p>The levels of ROS were estimated indirectly by measuring the fluorescence emitted by dichlorofluo...
<p>FRTL-5 cells were grown in 12-well plates to 60% confluency in 6H5% medium, and then shifted to 5...
<p>Cell viability of A) primary human hepatocytes (n = 2), HepG2 and Hep3B cells (n = 3) after stimu...
Background: The clinic therapeutic effect of resveratrol is limited due to its low oral bioavailabil...
<p>Cells were pre-incubated with 25 µM Resv or 500 µM 5-ASA or both (25 µM Resv plus 500 µM 5-ASA) a...
<p>The initial concentration of resveratrol or FUDR in the medium was 100 µM or 50 µM (0 hr). The me...